About the Company
We do not have any company description for Journey Medical Corp at the moment.
Exchange
NASDAQ
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $DERM News
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
Companygeneratedtotalrevenuesof$79.2millionfor the full year ended December 31, 2023,a7%increasefrom the $73.7 million reported in 2022Achieved ...
Q4 2023 Journey Medical Corp Earnings Call
Srinivas Sidgiddi; Vice President, Research & Development; Journey Medical Corp ...
Journey Medical (DERM) Up as FDA Accepts Skin Disease Drug NDA
Journey Medical Corporation's DERM shares rose 10% on Mar 18, after the company announced that its new drug application (NDA) ...
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
We are pleased that the FDA has set a PDUFA date of November 4, 2024 for DFD-29 and we look forward to collaborating with the agency throughout the review process in order to bring this unique ...
Journey Medical Corporation (DERM) Q4 2023 Earning Call Transcript
Joining me from Journey Medical Corporation’s leadership team are, Claude Maraoui, Co-Founder, President and Chief Executive Officer; Joseph Benesch, Interim Chief Financial Officer; Dr ...
Director Justin Smith Acquires 30,000 Shares of Journey Medical Corp (DERM)
Journey Medical Corp (NASDAQ:DERM) has reported an insider purchase according to the latest SEC filings. Director Justin ...
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
SCOTTSDALE, Ariz., March 21, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage ...
Q4 2023 Journey Medical Corp Earnings Call
Q4 2023 Journey Medical Corp Earnings Call Q4 2023 Journey Medical Corp Earnings Call HOME MAIL NEWS FINANCE SPORT CELEBRITY STYLE WEATHER MORE... Yahoo Finance Sign in Mail Sign in to view your ...
Loading the latest forecasts...